Padlock Therapeutics Overview

  • Founded
  • 2014
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 10
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $600M
Latest Deal Amount

Padlock Therapeutics General Information

Description

Provider and developer of novel drugs. This company is focused on discovering novel therapeutics that target protein arginine deiminases an emerging class of enzymes with roles in autoimmunity and epigenetic control.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Primary Office
  • 200 Cambridge Park Drive
  • Cambridge, MA 02140
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Padlock Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Apr-2016 $600M 0000 00000 Completed Generating Revenue
1. Early Stage VC (Series A) 18-Dec-2014 0000 0000 000.00 Completed Startup
To view Padlock Therapeutics’s complete valuation and funding history, request access »

Padlock Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A3 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A2 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A1 2,006,095 $0.000100 $1 $1 1x $1 7.04%
To view Padlock Therapeutics’s complete cap table history, request access »

Padlock Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider and developer of novel drugs. This company is focused on discovering novel therapeutics that target protein arg
Drug Discovery
Cambridge, MA
10 As of 2016
0000
0000 0000-00-00
000000&0 0000

000000

lor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint
0000 000000000
Seattle, WA
00 As of 0000
000.00
0000000000 0 000.00

0000000

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariat
0000000000000
Brisbane, CA
000 As of 0000
000.00
00000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Padlock Therapeutics Competitors (24)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kineta Venture Capital-Backed Seattle, WA 00 000.00 0000000000 0 000.00
0000000 0000000000 Formerly VC-backed Brisbane, CA 000 000.00 00000000 000.00
0000000 000000 Formerly VC-backed New York, NY 000 00000 00000000 00000
000000 00000000000 Venture Capital-Backed Lexington, MA 00 00000 00000000 00000
000000 00000000000 Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
You’re viewing 5 of 24 competitors. Get the full list »

Padlock Therapeutics Patents

Padlock Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3510025-A1 Heteroaryl inhibitors of pad4 Pending 12-Sep-2016 000000000
JP-2019526606-A Heteroaryl inhibitors of pad4 Pending 12-Sep-2016 000000000
US-20210299115-A1 Heteroaryl inhibitors of pad4 Pending 12-Sep-2016 0000000000
US-20190358216-A1 Heteroaryl inhibitors of pad4 Granted 12-Sep-2016 000000000
US-11026937-B2 Heteroaryl inhibitors of pad4 Active 12-Sep-2016 A61K31/47 00

Padlock Therapeutics Executive Team (6)

Name Title Board Seat Contact Info
Michael Gilman Ph.D Chief Executive Officer, Board Member & Co-Founder
Rajesh Devraj Ph.D Chief Scientific Officer
You’re viewing 2 of 6 executive team members. Get the full list »

Padlock Therapeutics Board Members (7)

Name Representing Role Since
Adelene Perkins Self Board Member 000 0000
Marian Nakada Ph.D Self Board Member 000 0000
Rab Prinjha Ph.D Padlock Therapeutics Board Observer 000 0000
You’re viewing 3 of 7 board members. Get the full list »

Padlock Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Padlock Therapeutics Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Atlas Venture Venture Capital Minority 000 0000 000000 0
Index Ventures Venture Capital Minority 000 0000 000000 0
Johnson & Johnson Innovation - JLABS Accelerator/Incubator 000 0000 000000 0
M Ventures Corporate Venture Capital Minority 000 0000 000000 0
The Scripps Research Institute Corporation Minority 000 0000 000000 0
To view Padlock Therapeutics’s complete investors history, request access »